U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07585669) titled 'Effects of Omega-3 Fatty Acids on Inflammation and Gut Microbiota in Celiac Disease' on May 06.
Brief Summary: The goal of this clinical trial is to learn if omega-3 fatty acid supplements (n-3 PUFAs) can help reduce inflammation and promote intestinal healing in adults newly diagnosed with celiac disease (CD).
Celiac disease is a chronic autoimmune disorder where eating gluten-a protein found in wheat-triggers an immune response that damages the lining of the small intestine. This damage causes inflammation and symptoms such as stomach pain, diarrhea, and nutrient absorption problems. The only current treatment is a strict gluten-f...